1. Denis, JB. Concerning a new way of curing. Philosophical Transactions. 1667; 489-504.
2. Carnot P, Deflandre, C. On the hemopoietic activity of serum during the regeneration of blood. [French] C. R. Acad. Sci. 1906; 143: 348-387.
3. Goldwasser E. Erythropoietin: a somewhat personal history. Perspect Biol Med. 1996; 40(1): 18-32. doi: 10.1353/pbm.1996.0005
4. Lin F-K, Suggs S, Lin C-H, et al. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci. 1985; 82: 7580- 7584.
5. Maiese K, Li F, Chung Z. Erythropoietin in the brain: can the promise to protect be fulfilled? Trends Pharmacol Sci. 2004; 25: 577-583. doi: 10.1016/j.tips.2004.09.006
6. Nakano M, Satoh K, Fukumoto Y, et al. Important role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in mice. Circ Res. 2007; 100: 662-669. doi: 10.1161/01.RES.0000260179.43672.fe
7. Maiese K, Li F, Chong ZZ. New avenues of exploration for erythropoietin. JAMA. 2005; 293: 90-95. doi: 10.1001/jama.293.1.90
8. Westenfelder C, Biddle DL, Baranowski RL. Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int. 1999; 55: 808-820.
9. Spandou E, Tsouchnikas I, Karkavelas G, et al. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Nephrol Dial Transplant. 2006; 21: 330-336. doi: 10.1093/ndt/gfi177
10. Sharples EJ, Patel N, Brown P, et al. Erythropoietin protects the kidney against injury and dysfunction caused by ischemiareperfusion. J Am Soc Nephrol. 2004; 15: 2115-2124. doi: 10.1097/01.ASN.0000135059.67385.5D
11. Ates E, Yalcin AU, Yilmaz S, Koken T, Tokyol C. Protective effect of erythropoietin on renal ischemia and reperfusion injury. ANZ J Surg. 2005; 75: 1100-1105. doi: 10.1111/j.1445-2197.2005.03612.x
12. Johnson DW, Pat B, Vesey DA, Guan Z, Endre Z, Gobe GC. Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney Int. 2006; 69: 1806-1813.
13. Maio R, Sepodes B, Patel NS, Thiemermann C, Mota-Filipe H, Costa P. Erythropoietin preserves the integrity and quality of organs for transplantation after cardiac death. Shock. 2011; 35: 126-133. doi: 10.1097/SHK.0b013e3181e83236
14. Forman CJ, Johnson DW, Nicol DL. Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigs. BJU Int. 2007; 99: 162-165. doi: 10.1111/j.1464-410X.2006.06505.x
15. Sølling C, Christensen AT, Krag S, et al. Erythropoietin administration is associated with short term improvement in glomerular filtration rate after ischemia-reperfusion injury. Acta Anaesthesiol Scand. 2011; 55: 185-195. doi: 10.1111/j.1399-6576.2010.02369.x
16. Ishii Y, Sawada T, Murakami T, et al. Renoprotective effect of erythropoietin against ischaemia reperfusion injury in a nonhuman primate model. Nephrol Dial Transplant. 2011; 26: 1157-1162. doi: 10.1093/ndt/gfq601
17. Aydin Z, Mallat MJ, Schaapherder AF, et al. Randomized trial of short course high-dose erythropoietin in donation after cardiac death kidney transplant recipients. Am J Transplant. 2012; 12: 1793-1800. . doi: 10.1111/j.1600-6143.2012.04019.x
18. Hafer C, Becker T, Kielstein JT, et al. High-dose erythropoietin has no effect on short- or long-term graft function following deceased donor kidney transplantation. Kidney Int. 2012; 81: 314-320. doi: 10.1038/ki.2011.349
19. Martinez F, Kamar N, Pallet N, et al. High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: results of the Neo-PDGF Study. Am J Transplant. 2010; 10: 1695-1700. doi: 10.1111/j.1600-6143.2010.03142.x
20. Sureshkumar KK, Hussain SM, Ko TY, Thai NL, Marcus RJ. Effect of high-dose erythropoietin on graft function after kidney transplantation: a randomized, double-blind clinical trial. Clin J Am Soc Nephrol. 2012; 7: 1498-1506.
21. Song YR, Lee T, You SJ, et al. Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery by pass grafting: a pilot study. Am J Nephrol. 2009; 30: 253-260. doi: 10.1159/000223229
22. deSeigneux S, Ponte B, Weiss L, et al. Epoetin administrated after cardiac surgery: effects on renal function and inflammation in a randomized controlled study. BMC Nephrol. 2012; 13: 132. doi: 10.1186/1471-2369-13-132
23. Matejkova S, Scheuerle A, Wagner F, et al. Carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine kidney ischemia/reperfusion injury. Intensive Care Med. 2013; 39(3): 497-510. doi: 10.1007/s00134-012-2766-y